期刊文献+

2002-2007年我院抗结核药应用与耐药性探讨 被引量:4

Study of the Utilization and Drug Resistance of Antituberculotics in Our Hospital During 2002-2007
暂未订购
导出
摘要 目的:探讨抗结核药物的应用与其耐药性之间的关系,为合理应用药物提供参考。方法:统计我院2002—2007年9种常用抗结核药:乙胺丁醇、异烟肼、利福平、吡嗪酰胺、左氧氟沙星、利福喷丁、丙硫异烟胺、链霉素、对氨基水杨酸钠等的用药频度及耐药情况,计算相关系数,描述用药频度与耐药性的相关性及相关性之间的密切程度。结果:结核菌对这9种抗结核药的耐药率与其用药频度的相关系数在O.7536~0.9794之间,相关系数均具显著性。结论:细菌耐药率与药物的DDDs之间存在正相关,所以合理使用药物,可减少耐药性的发生。 Objective: To investigate the relationship between the application of antituberculosis drugs and the drug resistance and provide references for the rational drug use. Methods: The DDDs and the drug resistance of nine commonly used antituberculotics in our hospital from 2002 to 2007 were statistically analyzed, including ethambutol, isoniazid, rifampicin, pyrazinamide, levofloxacin, rifapentine, protionamide, streptomycin, sodium aminosalicylate. The relevant coefficients were calculated in order to determine the relevance and its closeness of DDDs and the drug resistance. Results: The relevant coefficients of the resistance rate and the DDDs ranged from 0.753 6 to 0.979 4, which had significance. Conclusion: There is a positive correlation between the tuherculotics resistance rate and the DDDs. As a result, the rational application of drugs can reduce the occurrence of the tuberculotics resistance.
作者 张昕 刘亚敏
出处 《中国药物应用与监测》 CAS 2009年第2期82-84,共3页 Chinese Journal of Drug Application and Monitoring
关键词 抗结核药物 耐药性 用药频度 相关系数 Antituberculotics Drug resistance DDDs Relevant coefficient
  • 相关文献

参考文献3

二级参考文献24

  • 1邹豪,邵元福,朱才娟,邓渝林,马玉杰,陈盛新.医院药品DDD数排序分析的原理及利用[J].中国药房,1996,7(5):215-217. 被引量:1428
  • 2金有豫.药理学第5版[M].北京:人民卫生出版社,2001.111.
  • 3卢平 杨永弘 许淑珍.北京儿童医院1991—1995年畅销药比较分析[J].中国药房,1996,4:170-170.
  • 4Abbate E,Dilonarde M,Isola N,et al.Increasing mult-iple drug resistant tuberculosis in AIDS patients in Bue-nos AiresCity,Argentina[J]. Tuber Lung Dis,1995,76 (2):135.
  • 5Iseman MD. Treatment of multidrug-resistant tuberc-ulosis[J]. N Engl JMed,1993,329:784.
  • 6Antibiotical therapeutic chemical (ATC) classification index with Defined daily Doses (DDDS) [J]. WHO Collaborating Centre for Drug statistics Methodology, Olso Norway, 1997.
  • 7National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing[S]. Tenth informational supplement M100-S10.2000. 1-54.
  • 8Louie JP, Bell LM. Appropriate use of antibiotiocs for common infections in an era of increasing resistance[J]. Emerg Med Clin North Am,2002,20:69-91.
  • 9Seppala H, Klaukka T, Vuopio Varkila J, et al. The effect of changes in the consumption of macrolide antibiotica on crythro myein resistance in group A streptococei in Finland[J]. Finnish Study Group for Antimicrobial Resislance. N Engl J Med, 1997,337:441-446.
  • 10Van Kerkhoven D, Pectermans WE, Verbist L, et al. Breakthrough penumococcal bacteraemin in patients treated with clarithromycin or oral beta lactams[J]. J Antimicroh Chemother, 2003,51 : 691-696.

共引文献29

同被引文献30

  • 1贾卫,吴卫东,张伟,顾晓明,于静,阿依努尔,刘年强,陈鹏.WHO新疆结核病耐药监测报告[J].中国防痨杂志,2008,30(4):307-310. 被引量:24
  • 2赵慧玲,霍汉玲,郭本德,李永梅.32例耐多药肺结核患者疗效观察[J].中国医药指南,2008,6(15):258-259. 被引量:2
  • 3丁红芳,王红波.抗结核药物服用有效性探讨[J].中国误诊学杂志,2007,7(14):3422-3422. 被引量:6
  • 4朱友生.抗结核药物研究新进展[J].中国防痨杂志,2007,29(4):348-351. 被引量:8
  • 5卫生部.全国结核病耐药性基线调查报告[M].北京:人民军医出版社,2010,23-37.
  • 6肖和平,唐神结.耐药结核病防治手册[M].北京:人民卫生出版社,2009,88—89.
  • 7中国防痨协会基础专业委员会.结核病诊断实验室检验规程[M].北京:中国教育出版社,2006.13-16.
  • 8刘子秋,姜世闻,杜莹,等.结核病专科医院对住院肺结核患者的诊断与治疗现状[J].中国防痨杂志,2007,29(增):153.
  • 9赵雁林,王黎霞,成诗明,等.分枝杆菌分离培养标准化操作程序及质量保证手册[M].北京:人民卫生出版社,2013:4.
  • 10WHO.Global tuberculosis control:surveillance,planning,financing[C].WHO Report 2010.World Health Organization,Geneva,WHO/HTM/TB/2010.376.

引证文献4

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部